How much funding has Ascribe Bioscience raised?

Ascribe Bioscience has raised $13.0M in total funding, most recently a Series A round.

Who are Ascribe Bioscience's investors?

Ascribe Bioscience's investors include Acre Venture Partners, The Yield Lab, National Science Foundation, Corteva, Grow-NY, NSF.

When was Ascribe Bioscience founded?

Ascribe Bioscience was founded in 2017.

Where is Ascribe Bioscience headquartered?

Ascribe Bioscience is headquartered in Ithaca, New York, United States.

What industry is Ascribe Bioscience in?

Ascribe Bioscience operates in Agtech, Biotech, Crop Protection.

How many employees does Ascribe Bioscience have?

Ascribe Bioscience has 1-10 employees.

Ascribe Bioscience

Harnessing Small Molecules for Natural Crop Protection

Ithaca, United States · Founded 2017 · $13.0M raised

Agtech

Biotech

Crop Protection

Headquarters: Ithaca, New York
Employees: 1–10
Founded: 2017
Business Model: B2B

Website: ascribebio.com
Total Funding: $13.0M
Last Round: $12.0M Series AOct 2025
Rounds: 6

About

Ascribe Bioscience is an Ithaca, NY-based agricultural biotechnology company developing natural crop protection solutions derived from small molecules discovered in the soil microbiome. Founded in 2017 from research at the Boyce Thompson Institute and Cornell University, Ascribe's platform applies metabolomics to identify bioactive compounds that prime plant immune systems against crop pathogens. Its flagship product, Phytalix, is a biofungicide that delivers the sustainability benefits of biologicals with the efficacy and ease of use of conventional chemical crop protection, targeting diseases including Bacterial Leaf Blight in rice. The company raised a $12 million Series A in October 2025 to advance its next-generation product pipeline.

Summary

Ascribe Bioscience is an Agtech company based in Ithaca, United States, founded in 2017. It has raised $13.0M in total across 6 rounds, most recently a $12.0M Series A round in Oct 2025. Investors include Acre Venture Partners, The Yield Lab and National Science Foundation.

LinkedIn X (Twitter)